These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12350196)

  • 21. Issues and challenges for managed care in the treatment of asthma and chronic obstructive pulmonary disease.
    Schoening SK
    Am J Manag Care; 2004 Jul; 10(5 Suppl):S158-63. PubMed ID: 15354681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The challenge of differentiating asthma from chronic obstructive pulmonary disease.
    Hanania NA
    Manag Care; 2005 Jul; 14(7 Suppl Obstructie Lung):9-15; discussion 24-6. PubMed ID: 18564559
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacist care for reactive airway disease.
    Ghosh AK
    JAMA; 2003 Mar; 289(9):1104; author reply 1105-6. PubMed ID: 12622574
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacist care for reactive airway disease.
    Jameson J; Plas AJ
    JAMA; 2003 Mar; 289(9):1104; author reply 1105-6. PubMed ID: 12622577
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacist care for reactive airway disease.
    Gans JA; Williams JM
    JAMA; 2003 Mar; 289(9):1105; author reply 1105-6. PubMed ID: 12622573
    [No Abstract]   [Full Text] [Related]  

  • 26. Management and treatment of reversible airway disease.
    Schoening SK
    Am J Manag Care; 2004 Jul; 10(5 Suppl):S127-8. PubMed ID: 15354677
    [No Abstract]   [Full Text] [Related]  

  • 27. Monitoring pulmonary function in asthma and COPD: point-of-care testing.
    Tovar JM; Gums JG
    Ann Pharmacother; 2004 Jan; 38(1):126-33. PubMed ID: 14742806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outpatient management of asthma.
    Bowersox MT
    West J Med; 1993 May; 158(5):516-7. PubMed ID: 8342270
    [No Abstract]   [Full Text] [Related]  

  • 29. The European COPD Audit: a pilot experience of 16 European countries.
    Hartl S
    Pneumonol Alergol Pol; 2012; 80(6):501-4. PubMed ID: 23109200
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical year in review IV: asthma, chronic obstructive pulmonary disease, host-microbe interactions in airways disease, and pulmonary vascular disease.
    Rand Sutherland E
    Proc Am Thorac Soc; 2011 Sep; 8(5):411-7. PubMed ID: 21926391
    [No Abstract]   [Full Text] [Related]  

  • 31. [Current treatment of asthma and COPD has forgotten the peripheral bronchial relaxation. The small airways play a key role].
    Persson C
    Lakartidningen; 2007 Sep 12-18; 104(37):2589-90. PubMed ID: 17970393
    [No Abstract]   [Full Text] [Related]  

  • 32. Towards individualised medicine for airways disease: identifying clinical phenotype groups.
    Travers J; Weatherall M; Fingleton J; Beasley R
    Eur Respir J; 2012 Apr; 39(4):1033-4. PubMed ID: 22467724
    [No Abstract]   [Full Text] [Related]  

  • 33. [EUROPEAN COPD AUDIT in Poland--how do we treat the patients with COPD exacerbation?].
    Chorostowska-Wynimko J; Górecka D; Sliwiński P; Roszkowski-Śliż K
    Pneumonol Alergol Pol; 2012; 80(6):493-7. PubMed ID: 23109198
    [No Abstract]   [Full Text] [Related]  

  • 34. Older peoples' perception of tests used in the assessment and management of COPD and asthma.
    McDonald VM; Simpson JL; McElduff P; Gibson PG
    Clin Respir J; 2013 Oct; 7(4):367-74. PubMed ID: 23509896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of care assessment in COPD. AUDIPOC: the Spanish audit experience.
    Lopez-Campos JL; Pozo-Rodríguez F;
    Pneumonol Alergol Pol; 2012; 80(6):505-8. PubMed ID: 23109201
    [No Abstract]   [Full Text] [Related]  

  • 36. Inequities in ambulatory care and the relationship between socioeconomic status and respiratory hospitalizations: a population-based study of a canadian city.
    Trachtenberg AJ; Dik N; Chateau D; Katz A
    Ann Fam Med; 2014; 12(5):402-7. PubMed ID: 25354403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A systematic review of integrated use of disease-management interventions in asthma and COPD.
    Lemmens KM; Nieboer AP; Huijsman R
    Respir Med; 2009 May; 103(5):670-91. PubMed ID: 19155168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical use of Heliox in asthma and COPD.
    Valli G; Paoletti P; Savi D; Martolini D; Palange P
    Monaldi Arch Chest Dis; 2007 Sep; 67(3):159-64. PubMed ID: 18018756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Asthma and Chronic Obstructive Pulmonary Disease Overlap Syndrome: Doubled Costs Compared with Patients with Asthma Alone.
    Gerhardsson de Verdier M; Andersson M; Kern DM; Zhou S; Tunceli O
    Value Health; 2015 Sep; 18(6):759-66. PubMed ID: 26409602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Written action plans compared to medical management alone.
    National Asthma Education and Prevention Program
    J Allergy Clin Immunol; 2002 Nov; 110(5 Suppl):S183-91. PubMed ID: 12518560
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.